Our grants aim to enable people with diabetes to live longer and improve their quality of life and aim that fewer people develop diabetes. We also want to contribute to making Denmark a global leader within patient-centred treatment of diabetes.
In recent years, we have awarded grants to establish specialized Steno Diabetes Centers at public hospitals in Denmark’s five administrative regions. The ambition for the Centers is that they can offer the world’s best treatment and prevention of diabetes and also be a driving force in developing new treatment and prevention methods and teaching that benefit every person in Denmark with diabetes.
We have also established the Steno Collaborative Grants programme to support the collaboration between the research communities at Steno Diabetes Centers and research communities outside the Centers throughout Denmark.
We have supported treating people with diabetes since 1932, when Nordisk Insulinlaboratorium (one of the three foundations that merged into the Novo Nordisk Foundation) built Niels Steensens Hospital, where people with low incomes could receive treatment free of charge. From 1957, the hospital also successfully researched the causes and progression of diabetes in its laboratory. The hospital was later renamed Steno Diabetes Center.